OTC · Medical - Diagnostics & Research

bioMérieux S.A. (BMXMF) Stock

$80.31 +0.00% OTC: BMXMF Healthcare

Operating on a global scale, bioMérieux S.A. designs and produces in vitro diagnostic solutions specifically for detecting infectious diseases across the Americas, Europe, the Middle East, Africa, and Asia Pacific.

Valuation

MetricValue
Price$80.31
Market Cap$9.48B
P/E Ratio20.73
P/B Ratio2.01
P/S Ratio2.03
EPS (TTM)$3.87
52-Week High$152.00
52-Week Low$77.00
Dividend Yield1.41%

Financials & Margins

MetricValue
ROE9.89%
ROA7.13%
ROCE8.61%
Gross Margin53.07%
Operating Margin9.54%
Net Margin9.76%
Debt/Equity0.11
Current Ratio2.39

Annual Financials (USD)

Metric20212022202320242025
Revenue$3.4B$3.6B$3.7B$4.0B$4.1B
Operating Profit$784.0M$587.0M$439.0M$589.0M$654.0M
Net Profit$601.0M$452.0M$358.0M$432.0M$397.0M
EPS$5.06$3.82$3.01$3.64$3.34
Op Margin23.2%16.4%11.9%14.8%16.1%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$4.6B$5.2B$5.3B$5.8B$5.6B
Total Liabilities$1.4B$1.5B$1.5B$1.6B$1.5B
Cash$804.0M$553.0M$352.0M$450.0M$570.0M
Borrowings$463.0M$505.0M$519.0M$491.0M$461.0M

Latest News

bioMérieux introduces Salmonella testing kit on GENE-UP® TYPER to support root cause analysis in the food industry PR Newswire · Jun 18, 2026 Saudi Arabia In-Vitro Diagnostics (IVD) Market Report 2025-2034 Featuring Roche, Danaher, Abbott Laboratories, Thermo Fischer Scientific, Bio-Rad Laboratories, Sysmex, BD & Co, and Biomerieux GlobeNewswire · Apr 28, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$811.0M$475.0M$445.0M$667.0M$788.0M
Investing Cash Flow$-597.0M$-815.0M$-821.0M$-706.0M$-797.0M
Financing Cash Flow$-17.0M$-157.0M$0$-38.0M$-20.0M
Net Cash Flow$416.0M$-259.0M$-195.0M$109.0M$173.0M
Free Cash Flow$521.0M$188.0M$107.0M$322.0M$453.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-2.54
EV / EBITDA8.55
FCF Yield5.50%
Quick Ratio1.48
Interest Coverage24.58
Return 1Y-40.80%
Return 3Y-22.09%
Return 5Y—

Ownership

Insiders Held66.46%
Institutions Held17.12%
Institutions Float Held51.04%
Institutional HolderSharesReport Date
Pacer Advisors, Inc.2022026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAgilent Technologies, Inc. $137.39 -0.85% 25.52 $38.80B 0.59%
APDNApplied DNA Sciences, Inc. $5.62 +31.62% -0.05 $7.26M 0.00%
CDNA $43.71 +14.72% 18.87 $2.26B 0.00%
CRL $232.51 -0.90% -54.59 $11.20B 0.00%
DHRDanaher Corporation $196.55 -1.26% 33.17 $138.17B 0.75%

About bioMérieux S.A.

Operating on a global scale, bioMérieux S.A. designs and produces in vitro diagnostic solutions specifically for detecting infectious diseases across the Americas, Europe, the Middle East, Africa, and Asia Pacific. The firm's offerings encompass diagnostic systems that analyze biological samples to identify infectious diseases, cardiovascular conditions, and various types of cancer. Furthermore, it provides essential microbiological testing for quality assurance within the food, pharmaceutical, cosmetics, and veterinary industries. Its diverse clientele includes clinical and hospital laboratories, medical professionals, blood banks, and industrial control facilities. Founded in 1963, initially under the name B-D Mérieux, bioMérieux S.A. is headquartered in Marcy l'Etoile, France, and functions as a subsidiary of Institut Mérieux SA.

bioMérieux S.A. is headquartered in FR.

bioMérieux S.A. (BMXMF) stock trades at $80.31 with a market capitalization of $9.48B. The stock is valued at a price-to-earnings (P/E) ratio of 20.73, price-to-book of 2.01, price-to-sales of 2.03. Over the past 52 weeks the stock has ranged between $77.00 and $152.00, and currently trades 47.2% below its 52-week high. It pays a dividend yielding 1.41%.

On profitability, bioMérieux S.A. generates a return on equity (ROE) of 9.89%, return on capital employed of 8.61%, an operating margin of 9.54%, a net profit margin of 9.76%.

Official website: www.biomerieux.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides